Výsledky vyhledávání - "Joaquín Fra Rodríguez"

Complicaciones neutropénicas debidas a tratamiento citostático en pacientes con cáncer de mama tratadas con quimioterapia adyuvante. Estudio retrospectivo

Autor: Ricardo Hitt, Juan José Valerdi álvarez, Rafael Trujillo Vílchez, Emilio Alba Conejo, ángel Jiménez Lacave, José Andrés Moreno Nogueira, Joaquín Fra Rodríguez

Publikováno v: Revista de Oncología. 2:253-258

El estudio se llevo a cabo para conocer en una muestra de 309 mujeres con cancer de mama tratadas con quimioterapia adyuvante estandar el porcentaje de pacientes que recibe el 100% de la intensidad de dosis teorica prevista, profundizando en las caus

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ab8c623dbdc1ba988311e6a09860609f
https://doi.org/10.1007/bf02979565

Zobrazit plný text záznamu

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

Autor: Elisabetta Munzone, Zsolt Horváth, Lorenza Rimassa, Eva Sedlackova, Eva Segelov, Jose Luis González Larriba, Jorge Villanova Biazus, Ignazio CARRECA, Euan Walpole, David Wyld, Andrew Wardley, Pavel Vitek, Joaquín Fra Rodríguez, Timothy Perren, Tadeusz Pienkowski, Lubos Petruzelka, Laurence Gladieff

Publikováno v: Breast cancer research and treatment. 131(1)

Letrozole, an aromatase inhibitor, is ineffective in the presence of ovarian estrogen production. Two subpopulations of apparently postmenopausal women might derive reduced benefit from letrozole due to residual or returning ovarian activity: younger

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7041a908a1dbb8334e734766a715ebd
https://pubmed.ncbi.nlm.nih.gov/21892704

Zobrazit plný text záznamu

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer : the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

Summary Background Postmenopausal women with hormone receptor-positive early breast cancer have persistent, long-term risk of breast-cancer recurrence and death. Therefore, trials assessing endocrine therapies for this patient population need extende

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7bd5b09eeb5b509962aef78fc5bdfca
https://www.ncbi.nlm.nih.gov/pubmed/22018631

Zobrazit plný text záznamu

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer

Autor: Elisabetta Munzone, Zsolt Horváth, Lorenza Rimassa, Eva Segelov, Tamas Hickish, Javier Martin-Broto, Jose Luis González Larriba, Jorge Villanova Biazus, Ignazio CARRECA, David Wyld, Andrew Wardley, Joaquín Fra Rodríguez, Timothy Perren, Tadeusz Pienkowski, Laurence Gladieff

Publikováno v: The New England journal of medicine. 361(8)

BACKGROUND: The aromatase inhibitor letrozole, as compared with tamoxifen, improves disease-free survival among postmenopausal women with receptor-positive early breast cancer. It is unknown whether sequential treatment with tamoxifen and letrozole i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0518faf8e663df1014e643143d4948a9
https://pubmed.ncbi.nlm.nih.gov/20053139

Zobrazit plný text záznamu

Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer

Autor: Zsolt Horváth, Lorenza Rimassa, Eva Sedlackova, Eva Segelov, Tamas Hickish, Jose Luis González Larriba, Ignazio CARRECA, David Wyld, Andrew Wardley, Pavel Vitek, Joaquín Fra Rodríguez, Timothy Perren, Tadeusz Pienkowski, Lubos Petruzelka, Laurence Gladieff

Publikováno v: Clinical trials (London, England). 6(3)

Background Aromatase inhibitors provide superior disease control when compared with tamoxifen as adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer. Purpose To present the design, history, and analytic challenges

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::470da467f924f114dceef509d27e0dc0
https://pubmed.ncbi.nlm.nih.gov/19528136

Zobrazit plný text záznamu

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(34)

PurposeTo evaluate the prognostic and predictive value of Ki-67 labeling index (LI) in a trial comparing letrozole (Let) with tamoxifen (Tam) as adjuvant therapy in postmenopausal women with early breast cancer.Patients and MethodsBreast Internationa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03bcd79c94b815d6def0b3a4ba5758dc
https://pubmed.ncbi.nlm.nih.gov/18981464

Zobrazit plný text záznamu

Optimization of the RT-PCR technique to detect melanoma cells in peripheral blood

Autor: Suárez, Ana, Joaquín Fra Rodríguez, Alonso, Rebeca, Sánchez, Rosa, Lacave, Angel J., Gutiérrez, Carmen

Publikováno v: Europe PubMed Central
ResearcherID
Scopus-Elsevier
Joaquín Fra Rodríguez

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0e24a6393cc08455626c866ea9f7482b
http://europepmc.org/abstract/med/12168906

Zobrazit plný text záznamu

Treatment of ifosfamide encephalopathy with intravenous thiamin

Autor: Buesa, José M., García-Teijido, Paula, Losa, Raquel, Joaquín Fra Rodríguez

Publikováno v: Joaquín Fra Rodríguez
Scopus-Elsevier

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6ce45aa38cc0d3ab42820add1a320e37
http://clincancerres.aacrjournals.org/cgi/content/full/9/12/4636

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání